EDENvsIBRN
iShares MSCI Denmark ETF against iShares Neuroscience and Healthcare ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| EDEN | IBRN | |
|---|---|---|
| Expense ratio | 0.53% | 0.47% |
| Assets | $192M | $7931.50T |
| Net flow, 1 month | −$20M | +$2M |
| Net flow, 1 year | −$7M | +$2M |
| Return, YTD | +1.1% | +27.9% |
| Return, 1 year | +6.5% | +68.6% |
| Avg daily volume | 12K | 3K |
| Holdings | 51 | 54 |
| Listed | Jan 24, 2012 | Aug 23, 2022 |
| Options market | No | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS